These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 23130761

  • 1. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J, Mwethera PG, Hussey GD, Wiysonge CS.
    BMC Infect Dis; 2012 Nov 06; 12():289. PubMed ID: 23130761
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of vaginal microbicides in preventing HIV transmission.
    Musekiwa A, Fernando NB, Abariga SA.
    Trop Med Int Health; 2020 Jul 06; 25(7):790-802. PubMed ID: 32306503
    [Abstract] [Full Text] [Related]

  • 5. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 Jul 06; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
    J Int AIDS Soc; 2015 Jul 06; 18(1):20536. PubMed ID: 26700845
    [Abstract] [Full Text] [Related]

  • 9. The last decade of microbicide clinical trials in Africa: from hypothesis to facts.
    Ramjee G, Kamali A, McCormack S.
    AIDS; 2010 Oct 06; 24 Suppl 4():S40-9. PubMed ID: 21042052
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M, Wilcher R, Montgomery ET, Pool R, Schuler S, Lenzi R, Friedland B.
    J Int AIDS Soc; 2014 Oct 06; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [Abstract] [Full Text] [Related]

  • 12. Boost for vaginal microbicides against HIV.
    Lange JM, Karam M, Piot P.
    Lancet; 1993 Nov 27; 342(8883):1356. PubMed ID: 7901643
    [Abstract] [Full Text] [Related]

  • 13. The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies.
    Poynten IM, Millwood IY, Falster MO, Law MG, Andresen DN, Van Damme L, Kaldor JM.
    AIDS; 2009 Jun 19; 23(10):1245-54. PubMed ID: 19474652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
    Sidibe S, Pack AP, Tolley EE, Ryan E, Mackenzie C, Bockh E, Githuka G.
    J Int AIDS Soc; 2014 Jun 19; 17(3 Suppl 2):19151. PubMed ID: 25224612
    [Abstract] [Full Text] [Related]

  • 18. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM, Lees S, Stadler J, Morar NS, Ssali A, Mwanza B, Mntambo M, Phillip J, Watts C, Pool R.
    AIDS Care; 2008 Jul 19; 20(6):733-40. PubMed ID: 18576176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.